179 related articles for article (PubMed ID: 36110988)
1. Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria.
Zhang S; Xu L; Dai F; Wang P; Luo J; Zhang M; Xu M
Ann Transl Med; 2022 Aug; 10(16):866. PubMed ID: 36110988
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
3. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
[TBL] [Abstract][Full Text] [Related]
4. Novel Nomogram Based on Inflammatory Markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma.
Gu Y; Zheng F; Zhang Y; Qiao S
Cancer Manag Res; 2022; 14():895-907. PubMed ID: 35256861
[TBL] [Abstract][Full Text] [Related]
5. A Nomogram Estimation for the Risk of Microvascular Invasion in Hepatocellular Carcinoma Patients Meeting the Milan Criteria.
Pan C; Liu X; Zou B; Chin W; Zhang W; Ye Y; Liu Y; Yu J
J Invest Surg; 2022 Mar; 35(3):535-541. PubMed ID: 33655806
[TBL] [Abstract][Full Text] [Related]
6. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.
Ma KW; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM; Chok KSH
Surg Today; 2019 Jun; 49(6):521-528. PubMed ID: 30637484
[TBL] [Abstract][Full Text] [Related]
7. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.
Zhou Q; Zhou C; Yin Y; Chen W; Liu C; Atyah M; Weng J; Shen Y; Yi Y; Ren N
Ann Transl Med; 2021 Mar; 9(5):402. PubMed ID: 33842623
[TBL] [Abstract][Full Text] [Related]
9. A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.
Zhang JS; Wang ZH; Guo XG; Zhang J; Ni JS
J Gastrointest Oncol; 2022 Feb; 13(1):298-310. PubMed ID: 35284131
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Prognostic Nomogram to Predict the Long-Time Prognosis in Non-B, Non-C Hepatocellular Carcinoma.
Lin K; Huang Q; Huo Y; Zeng J; Ding Z; Guo P; Chen Z; Zeng Y; Liu J
Cancer Manag Res; 2020; 12():7771-7781. PubMed ID: 32943923
[TBL] [Abstract][Full Text] [Related]
11. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
12. Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression.
Luo D; Li H; Hu J; Zhang M; Zhang S; Wu L; Han B
Front Oncol; 2020; 10():548744. PubMed ID: 33344225
[TBL] [Abstract][Full Text] [Related]
13. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis.
Zhang C; Zhao R; Chen F; Zhu Y; Chen L
Transl Oncol; 2021 Jan; 14(1):100875. PubMed ID: 32979686
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.
Tian Y; Wang Y; Wen N; Lin Y; Liu G; Li B
Front Oncol; 2024; 14():1395740. PubMed ID: 38854717
[TBL] [Abstract][Full Text] [Related]
16. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
17. Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients.
Wang X; Yu Y; Tao Y; Wang Y; Zhang C; Cui Y; Zhou Y
J Hepatocell Carcinoma; 2023; 10():2323-2335. PubMed ID: 38146465
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
19. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.
Xu L; Li L; Wang P; Zhang M; Zhang Y; Hao X; Yan L; Li B; Wen T; Xu M
Gut Liver; 2019 Nov; 13(6):669-682. PubMed ID: 30970430
[TBL] [Abstract][Full Text] [Related]
20. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
